ProQR Therapeutics (NASDAQ:PRQR) Raised to “Buy” at StockNews.com
StockNews.com upgraded shares of ProQR Therapeutics (NASDAQ:PRQR – Free Report) from a hold rating to a buy rating in a research note released on Thursday. Several other equities analysts also recently commented on the stock. Chardan Capital raised shares of ProQR Therapeutics from a neutral rating to a buy rating and set a $2.00 target […]
More Stories
Rollbit Coin (RLB) Price Reaches $0.0717 on Major Exchanges
Rollbit Coin (RLB) traded down 2.7% against the dollar during the 1-day period ending at 22:00 PM E.T. on October...
Nexo Price Tops $1.01 on Major Exchanges (NEXO)
Nexo (NEXO) traded 1.1% lower against the dollar during the one day period ending at 22:00 PM ET on October...
Analyzing KYN Capital Group (OTCMKTS:KYNC) and Open Lending (NASDAQ:LPRO)
KYN Capital Group (OTCMKTS:KYNC – Get Free Report) and Open Lending (NASDAQ:LPRO – Get Free Report) are both financial services...
Critical Review: Standard Lithium (SLI) vs. Its Peers
Standard Lithium (NYSE:SLI – Get Free Report) is one of 33 public companies in the “Chemicals & allied products” industry,...
ZClassic (ZCL) Trading 7.3% Higher This Week
ZClassic (ZCL) traded up 5.8% against the US dollar during the 24-hour period ending at 22:00 PM Eastern on October...
Bubblefong Achieves Self Reported Market Cap of $5.12 Million (BBF)
Bubblefong (BBF) traded 4.7% lower against the US dollar during the 1-day period ending at 22:00 PM Eastern on October...